Regulatory Approval of Three Rapid Microbiological Methods for MACI® Product Release

Introduction Autologous cell therapy products are patient-specific therapies that utilize cells harvested from a single patient to treat that same patient. The patient-specific nature of these treatments mitigates potential safety concerns including viral contamination and immune response (rejection...

To read the full article and other articles in this issue, please register for a free account or log in.

We will not sell or give your information to a third party. See our Privacy Policy



Subscribe to our FREE newsletter

We will not sell or give your information to a third party. See our Privacy Policy